Advertisement

Topics

Companies Related to "Shire ADHD Drug Secures" [Most Relevant Company Matches] [Advanced Search Results] RSS

04:27 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "Shire ADHD Drug Secures" found in our extensive corporate database of over 50,000 company records.

Showing "Shire ADHD Drug Secures" Companies 1–25 of 3,500+

Extremely Relevant

Shire Ltd.

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the ...


Shire Ltd

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Sh...

Relevant

Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company’s extensive expertise in product development has been built over the past 20 years: initially as a stand alone development organization, then as a U.S. subsid...


CHADD

CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder) is the leading resource on attention-deficit/hyperactivity disorder (ADHD), providing support, training, education and advocacy for the 17 million children and adults in the United States living with ADHD, their families, educators and healthcare professionals. As home to the Nationa...

Shire plc

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is focused on developing specialty CNS products designed to address unmet medical needs. The company’s portfolio is well diversified with its two lead products Epliga® and Trokesa® for the treatment of epilepsy approaching NDA filings, followed by three products in the ADHD area, SPN810 and SPN812 in Phase II and S...

Highland Therapeutics Inc.

Highland Therapeutics Inc. is a specialty pharmaceutical company that, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc., is leveraging its proprietary technology, DELEXIS™, to optimize the delivery of previously approved drug products. The Company’s lead product candidates, HLD-200 and HLD-100, are novel formulati...

Shire

Founded in 1986, Shire plc is a global specialty pharmaceutical company with revenues for the full year 2005 of $1,599.3 million and an operating income of $(354.1) million. The growth rates for revenues were 17% for 2005 over the prior year. The Shire MissionShire’s mission is to develop and market medicines that improve the quality of life for patients and their caregivers. We do so through th...

BioBehavioral Diagnostics Company

BioBehavioral Diagnostics Company manufactures and markets the Quotient(TM) ADHD System, a tool that aids in the objective and accurate assessment of ADHD symptoms. We are dedicated to providing physicians, parents and patients with high-value information to guide personalized strategies and to enhance quality of life for patients with ADHD. Our vision is to provide accurate tools for the diagnosi...

Shire Limited

NLS Pharma

NLS/NLS-1 Pharma (NLS) – NLS is a Swiss based biotech group focusing on the repurposing of established and (cost-) effective drug/chemical compounds to treat Attention Deficit/HyperActivity Disorder (ADHD), sleep disorders and cognitive impairment.

McNeil Pediatrics(TM)

McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is committed to meeting the needs of children, adolescents, adults and healthcare professionals through the development of therapies specifically formulated for children, adolescents and adults. McNeil Pediatrics(TM) is a leader in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and markets a leading me...

Shire Pharmaceuticals

Bev Volpe (bvolpe@simonpr.com)

NextWave Pharmaceuticals

NextWave is an emerging specialty pharmaceutical company primarily focused on the development and commercialization of unique products for the treatment of cardiovascular and CNS diseases, with a pipeline of investigational drug candidates targeted for ADHD and related disorders. More information about NextWave is available at www.nextwavepharma.com.

CBSET Inc.

CBSET Inc., 500 Shire Way, Lexington, MA 02421 — is the preclinical research leader in critically important therapeutic fields such as interventional cardiology, renal disease and dialysis, chronic drug-resistant hypertension, women’s health, minimally invasive surgery, orthopedics, biological and synthetic tissue repair, drug delivery, bioresorb...

Medicine & Business Kft

Medicine & Business is an ambitious, dynamic organization with a comprehensive knowledge of the health care environment in Hungary. Medicine & Business is offering a mutually advantageous long-term partnership and assistance to develop a prosperous business which meets the consumer needs and thus secures growth via appropriate strategies and actions in a cost-effective way. Commitment to our partn...

Akili Interactive Labs, Inc.

Akili is building clinically-validated cognitive treatments and assessments that are delivered in an action video game interface. Leveraging medical-grade science and consumer-grade software technology, the company is seeking to produce a new type of medical product that can offer safe and effective scalable treatment and better monitoring for pa...

The Child and Adult Diagnostic and Treatment Program for ADHD

Curemark, LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children wi...

Curemark LLC

Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children wi...

Neurovance Inc.

Neurovance is a neuroscience-focused, clinical-stage biopharmaceutical company that specializes in triple reuptake inhibitors specifically optimized for adult attention deficit hyperactivity disorder (ADHD) and other CNS disorders. Neurovance is led by co-founders Anthony McKinney and Frank Bymaster, and is joined by other seasoned drug developers who have...

Gliatech Incorporated

Gliatech is engaged in the research, development and commercialization of ADCON, a family of proprietary, resorbable, carbohydrate polymer medical devices designed to inhibit surgical scarring and adhesions. In addition to the ADCON family of medical devices, the Company is pursuing the development of small molecule drug candidates for the treatment of several central nervous system disorders, inc...

Probably Relevant

AtEase

AtEase is a therapeutic glasses manufacturer whose product helps individuals suffering from anxiety and PTSD, and is dedicated to further research into helping with other areas of anxiety, migraines, ADHD and concussions. For more information, visit www.ateaseglasses.com.

CiTrials

At Clinical Innovations, our mission is to conduct Phase I-IV clinical trials in order to further the development of medications benefiting patients, communities, and physicians around the globe. Located in Southern California, CiTrials has the experience and expertise in performing Psychiatric and Internal medicine trials. From pediatric, first in human, single and multiple ascending dose, and...

Neurovance, Inc.

Neurovance has been spun out of Euthymics Bioscience, Inc. to advance EB-1020, a norepinephrine and dopamine-preferring reuptake inhibitor for ADHD. In addition to EB-1020, Neurovance also holds a substantial portfolio of research stage reuptake inhibitors.


More From BioPortfolio on "Shire ADHD Drug Secures"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks